Trademark: 88418271
Word
CP CRANBURY PHARMACEUTICALS
Status Date
Monday, December 25, 2023
Filing Date
Tuesday, May 7, 2019
Published for Opposition
Tuesday, September 29, 2020
Abandoned Date
Monday, December 25, 2023
5 Prescription and non-prescription pharmaceutical medicines and preparations for the treatment of cold and allergy symptoms, respiratory disease, asthma and chronic lung disease, upper respiratory symptoms, coughs, central nervous system disorders, namely, narcolepsy and attention deficit hyperactivity disorder, for the treatment of autism, schizophrenia, bipolar disorder, convulsions, epilepsy, nausea, vomiting, pruritus, for inducing sedation, for pain relief, and for anti-inflammation; dietary supplements; nutritional supplements; vitamins; nutritional supplements in the nature of nutriceuticals for use in treating nutritional deficiencies and as dietary supplements
The mark consists of interlocked letters "CP" and word portions "CRANBURY PHARMACEUTICALS".
Color is not claimed as a feature of the mark.
"PHARMACEUTICALS"
Dec 26, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Dec 25, 2023
Abandonment - No Use Statement Filed
May 18, 2023
Notice Of Approval Of Extension Request E-Mailed
May 17, 2023
Sou Extension 5 Granted
May 12, 2023
Sou Extension 5 Filed
May 12, 2023
Sou Teas Extension Received
Nov 5, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 3, 2022
Sou Extension 4 Granted
Nov 3, 2022
Sou Extension 4 Filed
Nov 3, 2022
Sou Teas Extension Received
Apr 29, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 27, 2022
Sou Extension 3 Granted
Apr 27, 2022
Sou Extension 3 Filed
Apr 27, 2022
Sou Teas Extension Received
Nov 25, 2021
Notice Of Approval Of Extension Request E-Mailed
Nov 23, 2021
Sou Extension 2 Granted
Nov 23, 2021
Sou Extension 2 Filed
Nov 23, 2021
Sou Teas Extension Received
Jun 23, 2021
Notice Of Approval Of Extension Request E-Mailed
Jun 22, 2021
Sou Extension 1 Granted
May 24, 2021
Sou Extension 1 Filed
Jun 22, 2021
Case Assigned To Intent To Use Paralegal
May 27, 2021
Notice Of Revival - E-Mailed
May 27, 2021
Sou Extension Received With Teas Petition
May 27, 2021
Petition To Revive-Granted
May 27, 2021
Teas Petition To Revive Received
Nov 24, 2020
Noa E-Mailed - Sou Required From Applicant
Sep 29, 2020
Official Gazette Publication Confirmation E-Mailed
Sep 29, 2020
Published For Opposition
Sep 9, 2020
Notification Of Notice Of Publication E-Mailed
Aug 25, 2020
Exparte Appeal Terminated
Aug 25, 2020
Approved For Pub - Principal Register
Aug 20, 2020
Teas/Email Correspondence Entered
Aug 20, 2020
Correspondence Received In Law Office
Aug 18, 2020
Teas Request For Reconsideration Received
Aug 18, 2020
Ex Parte Appeal-Instituted
Aug 18, 2020
Jurisdiction Restored To Examining Attorney
Aug 18, 2020
Exparte Appeal Received At Ttab
Feb 19, 2020
Notification Of Final Refusal Emailed
Feb 19, 2020
Final Refusal E-Mailed
Feb 19, 2020
Final Refusal Written
Jan 29, 2020
Teas/Email Correspondence Entered
Jan 29, 2020
Correspondence Received In Law Office
Jan 29, 2020
Assigned To Lie
Jan 23, 2020
Teas Response To Office Action Received
Jul 25, 2019
Notification Of Priority Action E-Mailed
Jul 25, 2019
Priority Action E-Mailed
Jul 25, 2019
Priority Action Written
Jul 25, 2019
Priority Action Written
Jul 22, 2019
Assigned To Examiner
May 23, 2019
Notice Of Design Search Code E-Mailed
May 22, 2019
New Application Office Supplied Data Entered
May 10, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
